These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24585459)

  • 1. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
    Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
    Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
    Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
    Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells.
    Cho HJ; Park SM; Kim IK; Nam IK; Baek KE; Im MJ; Yoo JM; Park SH; Ryu KJ; Han HT; Kim HJ; Hong SC; Kim KD; Pak Y; Kim JW; Lee CW; Yoo J
    Oncotarget; 2014 Mar; 5(6):1554-64. PubMed ID: 24721928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.
    Kim IK; Park SM; Cho HJ; Baek KE; Nam IK; Park SH; Ryu KJ; Ryu J; Choi J; Hong SC; Kim JW; Lee CW; Kang SS; Yoo J
    Oncotarget; 2013 Nov; 4(11):2045-56. PubMed ID: 24185104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in vivo in mice.
    Yao J; Da M; Guo T; Duan Y; Zhang Y
    Tumour Biol; 2013 Jun; 34(3):1493-501. PubMed ID: 23475632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLCγ is required for RhoGDI2-mediated cisplatin resistance in gastric cancer.
    Cho HJ; Baek KE; Nam IK; Park SM; Kim IK; Park SH; Im MJ; Ryu KJ; Yoo JM; Hong SC; Kim JW; Lee CW; Yoo J
    Biochem Biophys Res Commun; 2011 Oct; 414(3):575-80. PubMed ID: 21986528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
    Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
    Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXL5 attenuates RhoGDI2-induced cisplatin resistance in gastric cancer cells.
    Wu WD; Wang M; Ding HH; Qiu ZJ
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2551-7. PubMed ID: 27383304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer.
    Cho HJ; Baek KE; Park SM; Kim IK; Choi YL; Cho HJ; Nam IK; Hwang EM; Park JY; Han JY; Kang SS; Kim DC; Lee WS; Lee MN; Oh GT; Kim JW; Lee CW; Yoo J
    Clin Cancer Res; 2009 Apr; 15(8):2612-9. PubMed ID: 19351766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of chloroquine in combination with Cisplatin in human gastric cancer xenografts.
    Zhang HQ; Fang N; Liu XM; Xiong SP; Liao YQ; Jin WJ; Song RF; Wan YY
    Asian Pac J Cancer Prev; 2015; 16(9):3907-12. PubMed ID: 25987058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
    Wang ZM; Cui YH; Li W; Chen SY; Liu TS
    Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
    Zhou W; Wang J; Man WY; Zhang QW; Xu WG
    Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.
    Hamano S; Mori Y; Aoyama M; Kataoka H; Tanaka M; Ebi M; Kubota E; Mizoshita T; Tanida S; Johnston RN; Asai K; Joh T
    Cancer Lett; 2015 Jan; 356(2 Pt B):846-54. PubMed ID: 25444894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
    Zhu H; Yun F; Shi X; Wang D
    Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer.
    Koh SA; Kim MK; Lee KH; Kim SW; Kim JR
    Clin Exp Metastasis; 2014 Oct; 31(7):805-15. PubMed ID: 25253431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.